Fertility Treatment Leader Progyny Breaks Out Past Buy Point As Earnings Surge 113%Investors Business Daily • Monday
New Progyny Study Examines Persistent Racial and Ethnic Differences in Fertility Treatment Initiation Despite Access to BenefitsGlobeNewsWire • 10/28/26
New Progyny Study Finds Significant Improvement in Menopause Symptoms Through Connected Care ModelGlobeNewsWire • 10/26/26
Progyny to Present New Menopause Research at The Menopause Society 2026 Annual MeetingGlobeNewsWire • 10/15/26
Progyny, Inc. Selling Season Pacing to Record Level, Revealing Critical Insights on Latest Market DynamicsGlobeNewsWire • 10/07/26
Wall Street Analysts Predict a 25.23% Upside in Progyny (PGNY): Here's What You Should KnowZacks Investment Research • 09/09/26
Boost Your Portfolio Returns With These 4 Top-Ranked Liquid StocksZacks Investment Research • 08/10/26